Evotec AG today announced that its research alliance with Boehringer Ingelheim has achieved a milestone triggering a payment of EUR 4 million to Evotec. Die Original-Meldung zu diesem Chemie Unternehmen finden Sie unter https://www.evotec.com/en/investor-relations/news/corporate-news/p/pre-clinical–milestone-payment-as-part-of-its-discovery-alliance-with-boehringer-ingelheim-received-5020
